UniProt ID | RS24_HUMAN | |
---|---|---|
UniProt AC | P62847 | |
Protein Name | 40S ribosomal protein S24 | |
Gene Name | RPS24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 133 | |
Subcellular Localization | ||
Protein Description | Required for processing of pre-rRNA and maturation of 40S ribosomal subunits.. | |
Protein Sequence | MNDTVTIRTRKFMTNRLLQRKQMVIDVLHPGKATVPKTEIREKLAKMYKTTPDVIFVFGFRTHFGGGKTTGFGMIYDSLDYAKKNEPKHRLARHGLYEKKKTSRKQRKERKNRMKKVRGTAKANVGAGKKPKE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNDTVTIR -------CCCCEEEH | 10.38 | 22223895 | |
4 | Phosphorylation | ----MNDTVTIRTRK ----CCCCEEEHHHH | 17.97 | 19691289 | |
6 | Phosphorylation | --MNDTVTIRTRKFM --CCCCEEEHHHHHH | 13.56 | 24719451 | |
9 | Phosphorylation | NDTVTIRTRKFMTNR CCCEEEHHHHHHHHH | 34.07 | 28112733 | |
14 | Phosphorylation | IRTRKFMTNRLLQRK EHHHHHHHHHHHHHC | 21.96 | 21406692 | |
21 | Acetylation | TNRLLQRKQMVIDVL HHHHHHHCCHHHEEE | 29.77 | 26051181 | |
21 | Ubiquitination | TNRLLQRKQMVIDVL HHHHHHHCCHHHEEE | 29.77 | 21890473 | |
21 (in isoform 1) | Ubiquitination | - | 29.77 | 21890473 | |
21 (in isoform 2) | Ubiquitination | - | 29.77 | 21890473 | |
21 | Ubiquitination | TNRLLQRKQMVIDVL HHHHHHHCCHHHEEE | 29.77 | 21890473 | |
21 | Ubiquitination | TNRLLQRKQMVIDVL HHHHHHHCCHHHEEE | 29.77 | 21890473 | |
21 | Ubiquitination | TNRLLQRKQMVIDVL HHHHHHHCCHHHEEE | 29.77 | 21890473 | |
23 | Sulfoxidation | RLLQRKQMVIDVLHP HHHHHCCHHHEEECC | 2.98 | 30846556 | |
32 (in isoform 2) | Ubiquitination | - | 45.39 | 21890473 | |
32 | Acetylation | IDVLHPGKATVPKTE HEEECCCCCCCCHHH | 45.39 | 26051181 | |
32 | Ubiquitination | IDVLHPGKATVPKTE HEEECCCCCCCCHHH | 45.39 | 21890473 | |
32 (in isoform 1) | Ubiquitination | - | 45.39 | 21890473 | |
32 | Ubiquitination | IDVLHPGKATVPKTE HEEECCCCCCCCHHH | 45.39 | 21890473 | |
32 | Ubiquitination | IDVLHPGKATVPKTE HEEECCCCCCCCHHH | 45.39 | 21890473 | |
32 | Ubiquitination | IDVLHPGKATVPKTE HEEECCCCCCCCHHH | 45.39 | 21890473 | |
37 | Sumoylation | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 28112733 | |
37 | Sumoylation | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | - | |
37 | Ubiquitination | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 21890473 | |
37 | Acetylation | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 23749302 | |
37 | Ubiquitination | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 21890473 | |
37 (in isoform 1) | Ubiquitination | - | 55.22 | 21890473 | |
37 (in isoform 2) | Ubiquitination | - | 55.22 | 21890473 | |
37 | Ubiquitination | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 21890473 | |
37 | Ubiquitination | PGKATVPKTEIREKL CCCCCCCHHHHHHHH | 55.22 | 21890473 | |
38 | Phosphorylation | GKATVPKTEIREKLA CCCCCCHHHHHHHHH | 30.49 | 23312004 | |
46 | Ubiquitination | EIREKLAKMYKTTPD HHHHHHHHHHCCCCC | 53.88 | - | |
46 | Acetylation | EIREKLAKMYKTTPD HHHHHHHHHHCCCCC | 53.88 | 26051181 | |
49 | Ubiquitination | EKLAKMYKTTPDVIF HHHHHHHCCCCCEEE | 42.28 | - | |
50 | Phosphorylation | KLAKMYKTTPDVIFV HHHHHHCCCCCEEEE | 26.52 | 20068231 | |
62 | Phosphorylation | IFVFGFRTHFGGGKT EEEEEEECCCCCCCC | 21.21 | 20068231 | |
68 | Ubiquitination | RTHFGGGKTTGFGMI ECCCCCCCCCCEEEH | 46.30 | 21890473 | |
68 | Ubiquitination | RTHFGGGKTTGFGMI ECCCCCCCCCCEEEH | 46.30 | 21890473 | |
68 (in isoform 2) | Ubiquitination | - | 46.30 | 21890473 | |
68 | Acetylation | RTHFGGGKTTGFGMI ECCCCCCCCCCEEEH | 46.30 | 23954790 | |
68 | Ubiquitination | RTHFGGGKTTGFGMI ECCCCCCCCCCEEEH | 46.30 | 21890473 | |
68 (in isoform 1) | Ubiquitination | - | 46.30 | 21890473 | |
68 | Ubiquitination | RTHFGGGKTTGFGMI ECCCCCCCCCCEEEH | 46.30 | 21890473 | |
69 | Phosphorylation | THFGGGKTTGFGMIY CCCCCCCCCCEEEHH | 35.11 | 21406692 | |
70 | Phosphorylation | HFGGGKTTGFGMIYD CCCCCCCCCEEEHHH | 33.72 | 21406692 | |
74 | Sulfoxidation | GKTTGFGMIYDSLDY CCCCCEEEHHHCHHH | 2.10 | 30846556 | |
76 | Phosphorylation | TTGFGMIYDSLDYAK CCCEEEHHHCHHHHH | 7.21 | 28152594 | |
76 (in isoform 4) | Phosphorylation | - | 7.21 | 27642862 | |
78 | Phosphorylation | GFGMIYDSLDYAKKN CEEEHHHCHHHHHHC | 13.23 | 28152594 | |
81 | Phosphorylation | MIYDSLDYAKKNEPK EHHHCHHHHHHCCCC | 26.13 | 28152594 | |
81 (in isoform 4) | Phosphorylation | - | 26.13 | 27642862 | |
83 (in isoform 2) | Ubiquitination | - | 50.32 | 21890473 | |
83 | Ubiquitination | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 21890473 | |
83 | Ubiquitination | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 21890473 | |
83 | Ubiquitination | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 21890473 | |
83 | Ubiquitination | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 21890473 | |
83 | Acetylation | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 23236377 | |
83 | Succinylation | YDSLDYAKKNEPKHR HHCHHHHHHCCCCHH | 50.32 | 23954790 | |
83 (in isoform 1) | Ubiquitination | - | 50.32 | 21890473 | |
84 | Ubiquitination | DSLDYAKKNEPKHRL HCHHHHHHCCCCHHH | 59.37 | - | |
88 | Ubiquitination | YAKKNEPKHRLARHG HHHHCCCCHHHHHCC | 34.87 | - | |
99 | Ubiquitination | ARHGLYEKKKTSRKQ HHCCHHHHHHHCHHH | 46.11 | - | |
99 | Acetylation | ARHGLYEKKKTSRKQ HHCCHHHHHHHCHHH | 46.11 | 23749302 | |
100 | Ubiquitination | RHGLYEKKKTSRKQR HCCHHHHHHHCHHHH | 49.71 | - | |
115 | Acetylation | KERKNRMKKVRGTAK HHHHHHHHHHHHHHH | 44.90 | 19608861 | |
120 | Phosphorylation | RMKKVRGTAKANVGA HHHHHHHHHHCCCCC | 17.89 | - | |
122 | Sumoylation | KKVRGTAKANVGAGK HHHHHHHHCCCCCCC | 40.09 | - | |
122 | Acetylation | KKVRGTAKANVGAGK HHHHHHHHCCCCCCC | 40.09 | 25953088 | |
122 | Sumoylation | KKVRGTAKANVGAGK HHHHHHHHCCCCCCC | 40.09 | - | |
122 | Ubiquitination | KKVRGTAKANVGAGK HHHHHHHHCCCCCCC | 40.09 | - | |
129 | Ubiquitination | KANVGAGKKPKE--- HCCCCCCCCCCC--- | 66.42 | - | |
130 | Acetylation | ANVGAGKKPKE---- CCCCCCCCCCC---- | 61.48 | 13467605 | |
132 | Acetylation | VGAGKKPKE------ CCCCCCCCC------ | 82.19 | 13467609 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS24_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS24_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS24_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
610629 | Diamond-Blackfan anemia 3 (DBA3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-37, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-4, AND MASSSPECTROMETRY. |